Publication: Synergistic and Antagonistic Drug Combinations Depend on Network Topology
Open/View Files
Date
2014
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Yin, Ning, Wenzhe Ma, Jianfeng Pei, Qi Ouyang, Chao Tang, and Luhua Lai. 2014. “Synergistic and Antagonistic Drug Combinations Depend on Network Topology.” PLoS ONE 9 (4): e93960. doi:10.1371/journal.pone.0093960. http://dx.doi.org/10.1371/journal.pone.0093960.
Research Data
Abstract
Drug combinations may exhibit synergistic or antagonistic effects. Rational design of synergistic drug combinations remains a challenge despite active experimental and computational efforts. Because drugs manifest their action via their targets, the effects of drug combinations should depend on the interaction of their targets in a network manner. We therefore modeled the effects of drug combinations along with their targets interacting in a network, trying to elucidate the relationships between the network topology involving drug targets and drug combination effects. We used three-node enzymatic networks with various topologies and parameters to study two-drug combinations. These networks can be simplifications of more complex networks involving drug targets, or closely connected target networks themselves. We found that the effects of most of the combinations were not sensitive to parameter variation, indicating that drug combinational effects largely depend on network topology. We then identified and analyzed consistent synergistic or antagonistic drug combination motifs. Synergistic motifs encompass a diverse range of patterns, including both serial and parallel combinations, while antagonistic combinations are relatively less common and homogenous, mostly composed of a positive feedback loop and a downstream link. Overall our study indicated that designing novel synergistic drug combinations based on network topology could be promising, and the motifs we identified could be a useful catalog for rational drug combination design in enzymatic systems.
Description
Other Available Sources
Keywords
Biology and Life Sciences, Biochemistry, Biochemical Simulations, Computational Biology, Systems Biology, Medicine and Health Sciences, Clinical Medicine, Pharmacology, Drug Research and Development, Drug Interactions, Theoretical Pharmacology
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service